Avon’s Magellan Health Services announced Tuesday that its fourth quarter profits slipped nearly 10 percent, as declining commercial business hit the company’s bottom line.
Magellan’s net income for the quarter ending Dec. 31 totaled $29.7 million, or $1.05 per share, compared to $32.9 million, or 95 cents per share a year earlier.
For the full year 2011, Magellan said its profits totaled $129.6, or $4.13 per share, compared to $138.7 million, or $4.03 per share a year earlier.
 Fourth quarter revenues slipped about 4 percent to $721.4 million.
Despite the lower earnings, however, Magellan’s results beat analysts’ revenue estimates. Analysts, on an average, were expecting the company to earn 82 cents per share on revenue of $692.2 million, according to Thomson Reuters I/B/E/S.
“Magellan had a strong fourth quarter, which completed a successful 2011,” said René Lerer, Magellan’s chairman and CEO. “In addition to achieving solid financial results, our accomplishments during the year included attracting new customers, retaining existing customers and implementing a focused growth strategy in Medicaid and pharmacy. Contributing to Magellan’s success was strong performance in our radiology benefits management and Medicaid administration business segments. Additionally, our public sector and commercial behavioral health segments had important customer wins that are being implemented in the first quarter of 2012.”
Magellan management said its two leading strategic initiatives include expanding more broadly into the Medicaid market and providing comprehensive management for drug spending.
